Prospective collection of safety & activity information on patients with compassionate use prescription of experimental anticancer therapies in France is a reality – Pablo Berlanga Charriel

Honored to present at ASCO the results of the fantastic collaboration between the French Society of Pediatric Oncology (SFCE) and the French National Agency for the Safety of Medicines and Health Products (ANSM) within the SACHA France study (NCT04477681))

Prospective collection of safety & activity information on patients with compassionate use prescription of experimental anticancer therapies in France is a reality! It is already expanding to an international level!

Big thanks to the amazing ANSM team (Liora Brunel, Marie Gadeyne, Isabelle Yoldjian), the SACHA France team and all the SFCE centers. Thank you also to Imagine for Margo, Association Hubert Gouin and Fondation du LEEM for their funding support to SACHA France.

Source: Pablo Berlanga Charriel/Linkedin